These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
276 related items for PubMed ID: 25104566
21. Verification of the guidelines for lupus anticoagulant detection: usefulness of index for circulating anticoagulant in APTT mixing test. Kumano O, Ieko M, Naito S, Yoshida M, Takahashi N, Suzuki T, Aoki T. Thromb Res; 2014 Aug; 134(2):503-9. PubMed ID: 24935674 [Abstract] [Full Text] [Related]
26. Recurrent venous thrombosis despite 'optimal anticoagulation therapy' for antiphospholipid syndrome--could new oral anticoagulants solve the problem? Balaban M, Stanrić V, Rincić G, Ledinsky M, Grbac L, Stancić N, Tomasić H. Acta Clin Croat; 2010 Dec; 49(4):469-77. PubMed ID: 21830460 [Abstract] [Full Text] [Related]
27. Use of the chromogenic factor X assay in patients transitioning from argatroban to warfarin therapy. Austin JH, Stearns CR, Winkler AM, Paciullo CA. Pharmacotherapy; 2012 Jun; 32(6):493-501. PubMed ID: 22511112 [Abstract] [Full Text] [Related]
28. Monitoring of anticoagulation in thrombotic antiphospholipid syndrome. Cohen H, Efthymiou M, Devreese KMJ. J Thromb Haemost; 2021 Apr; 19(4):892-908. PubMed ID: 33325604 [Abstract] [Full Text] [Related]
29. INR Management of an Antiphospholipid Syndrome Patient With Point-of-Care INR Testing. Dush A, Erdeljac HP. J Pharm Pract; 2020 Jun; 33(3):390-391. PubMed ID: 30917725 [Abstract] [Full Text] [Related]
30. Rivaroxaban and false positive lupus anticoagulant testing. Merriman E, Kaplan Z, Butler J, Malan E, Gan E, Tran H. Thromb Haemost; 2011 Feb; 105(2):385-6. PubMed ID: 21103666 [No Abstract] [Full Text] [Related]
39. Use of the chromogenic factor X assay to predict the international normalized ratio in patients transitioning from argatroban to warfarin. Arpino PA, Demirjian Z, Van Cott EM. Pharmacotherapy; 2005 Feb 01; 25(2):157-64. PubMed ID: 15767231 [Abstract] [Full Text] [Related]